UL Solutions (ULS.N): Beat at EPS and EBITDA, but capex/sales up and Industrial misses: small +ve

Research evidence excerpt

UL Solutions (ULS.N): Beat at EPS and EBITDA, but capex/sales up and Industrial misses: small +ve

UL Solutions (ULS.N)

04 August 2026 Citi Research

OTHER DISCLOSURES

Any price(s) of instruments mentioned in recommendations are as of the prior day’s market close on the primary market for the

instrument, unless otherwise stated.

The completion and first dissemination of any recommendations made within this research report are as of the Eastern date-

time displayed at the top of the Product. If the Product references views of other analysts then please refer to the price chart or

rating history table for the date/time of completion and first dissemination with respect to that view.

Regulations in various jurisdictions require that where a recommendation differs from any of the author’s previous

recommendations concerning the same financial instrument or issuer that has been published during the preceding 12-month

period that the change(s) and the date of that previous recommendation are indicated. For fundamental coverage please refer

to the price chart or rating change history within this disclosure appendix or the issuer disclosure summary at

https://www.citivelocity.com/cvr/eppublic/citi_research_disclosures.

Citi Research has implemented policies for identifying, considering and managing potential conflicts of interest arising as a

result of publication or distribution of investment research. A description of these policies can be found

at https://www.citivelocity.com/cvr/eppublic/citi_research_disclosures.

The proportion of all Citi Research research recommendations that were the equivalent to "Buy","Hold","Sell" at the end of each

quarter over the prior 12 months (with the % of these that had received investment firm services from Citi in the prior 12 months